Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

9 Tech Stocks To Invest in From the Bargain Bin

By Dana Blankenhorn, InvestorPlace Contributor
Most tech stocks have fallen out of favor recently as investors seek value over growth.

7 Media Stocks Behind Big Upcoming 2021 Releases

By Josh Enomoto, InvestorPlace Contributor
Due to the lockdowns associated with the pandemic, media stocks took a hit in 2020. But they’re on the comeback trail this year.

It’s Time to Take Profits on Volatile BioNano Genomics Stock and Buy It Back on Dips

By Tezcan Gecgil, InvestorPlace Contributor
Without revenue growth, it's hard to be bullish on BNGO stock for the long-term

7 Beaten Down Stocks With Significant Insider Buying

By Mark Putrino, CMT
If the insiders are buying, other investors should at least pay attention. These seven stocks are ones to keep an eye on here.

Should SunPower Be in Your Portfolio of Sun Stocks?

By Will Ashworth, InvestorPlace Contributor
SunPower is one of the “sun stocks" Wall Street finds attractive in 2021. Should you buy SPWR stock on its own or as part of a portfolio?   

Ocugen Stock Isn’t Pricing In the Hard Road Ahead

By Vince Martin, InvestorPlace Contributor
OCGN stock has soared thanks to a Covid-19 vaccine partnership. But Ocugen needs time, capital, and competitive success that may not arrive.

Canopy Growth Stock Can Resist Any Cannabis Headwinds

By Josh Enomoto, InvestorPlace Contributor
With the discount in CGC stock, it may be time to advantage over due to encouraging consumer developments, but you should also be aware of the economic risks.

MoneyLine Podcast: Some of The Best Stock Ideas You’ll Hear About …

By InvestorPlace Research Staff
On today’s new episode of MoneyLine, Matt McCall dives into the recent pullback in some of the hottest stocks and discusses what you should be doing with your portfolio now.

Hyliion Produces Products on Target, But It Needs to Earn Revenue

By Mark R. Hake, CFA
Hyliion puts out products on target but it needs revenue. HYLN stock is worth over 16% more, provided it can hit $2 billion by 2024.

Silicon Valley Whiz Kid Reveals #1 Tech Stock in America

By InvestorPlace Staff
He uncovered peak gains: CHGG 2,063%, NIO 2,754%, AMD 4,793%, and BLNK 2,761%. Now he’s revealing his next tech stock recommendation for FREE.

The Core Reason Why Gevo Stock Is Still On the Riskier Side of Things

By Louis Navellier and the InvestorPlace Research Staff
Gevo is a biofuel producer that is in position to benefit from Joe Biden’s green energy plan, but GEVO stock’s big moves make it a risky bet.

Palantir: The Sell-Off Is Not Over

By Tom Taulli, InvestorPlace Contributor
PLTR has been hit hard -- which is the result of the general market bearishness and a disappointing earnings report.

Reddit Resurrects SNDL Stock but Normal Service Will Resume Soon

By Faizan Farooque, InvestorPlace Contributor
SNDL stock is not trading on fundamental strength after miraculously surviving. Shares are too speculative to merit a buy recommendation.

Pershing Square Tontine Has the Two Big SPAC Problems

By Vince Martin, InvestorPlace Contributor
At $29 and without a merger target, PSTH stock is now pricing in an incredible amount of deal value. It's unlikely to find that value.

Tilray Is Gathering Momentum for a Profitable 2021

By Louis Navellier and the InvestorPlace Research Staff
TLRY stock is already having an amazing 2021, but it's only the beginning. The Tilray-Aphria merger is expected to close in the second quarter of the year.

Why Nokia Stock is a Compelling Value Holding for the 5G Growth Ahead

By Chris Lau, InvestorPlace Contributor
NOK stock traded at above $9, albeit briefly, after Reddit users short-squeezed GameStop short-sellers and bought Nokia shares too.

All Bets are Off Whether Zomedica Stock Grows Into Its Valuation

By Thomas Niel, InvestorPlace Contributor
In the meantime, the company still needs to execute the commercialization of Truforma. If it experiences any hiccups along the way, shares could fall back to lower price levels. Reconsider ZOM stock as a buy if that happens. But, for now, hold off buying.

How to Navigate the Questionable Future of the Top 10 Meme Stocks

By Vince Martin, InvestorPlace Contributor
The rallies in January's meme stocks clearly went too far. After big pullbacks, however, some of the names may still have a long-term case.

Churchill Capital Bulls and Bears May Each Have Their Patience Rewarded

By Chris Markoch, InvestorPlace Contributor
The recent selloff in CCIV stock is requiring both bulls and bears to have patience while finding their respective entry or exit points.
Load More Articles